ADMA Biologics, Inc.ADMANASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank86
3Y CAGR+5.0%
Year-over-Year Change
Year-over-year operating income growth rate
3Y CAGR
+5.0%/yr
Annual compound
Percentile
P86
Within normal range
vs 3Y Ago
1.2x
Modest growth
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 37.75% |
| 2024 | 542.49% |
| 2023 | 154.95% |
| 2022 | 32.56% |
| 2021 | 10.08% |
| 2020 | -56.71% |
| 2019 | 31.29% |
| 2018 | -53.37% |
| 2017 | -126.83% |
| 2016 | -11.71% |